Basel Medical Group Ltd Ordinary Shares (BMGL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.63M | -302.73K |
| Operating CF Growth % | - | - |
| Operating CF / Revenue % | -19.77% | -5% |
| Net Income | 268.44K | -9.94M |
| Depreciation & Amortization | 2.05M | 799.14K |
| Stock-Based Compensation | 0 | 0 |
| Deferred Taxes | 0 | 0 |
| Other Non-Cash Items | 45.33K | 10.18M |
| Working Capital Changes | -3.99M | -1.34M |
| Cash from Investing | 224.88K | -10.48M |
| Capital Expenditures | -124.5K | -518.8K |
| Acquisitions | 349.39K | -9.96M |
| Purchase of Investments | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 |
| Other Investing | 0 | 0 |
| Cash from Financing | -715.26K | 6.98M |
| Dividends Paid | 0 | 0 |
| Share Repurchases | 0 | 0 |
| Stock Issued | 0 | 9.39M |
| Debt Issuance (Net) | 594.99K | -1000K |
| Other Financing | -1.31M | 649.21K |
| Net Change in Cash | -1.73M | -3.91M |
| Exchange Rate Effect | 389.23K | -115.93K |
| Cash at Beginning | 3.07M | 6.96M |
| Cash at End | 1.34M | 3.05M |
| Free Cash Flow | -1.75M | -821.53K |
| FCF Growth % | - | - |
| FCF Margin % | -21.28% | -13.57% |
| FCF per Share | -1.12 | -0.04 |